However, KLF4 expression is stimulated by treating CRC-derived cell lines with 5-Aza-2-deoxycytidine (5-Aza-dC), implicating underlying aberrant epigenetic modifications [3]. This evidence concerns the gene KLF4 and colorectal carcinoma.